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Abstract
Background: Retention in care and adherence to antiretroviral therapy (ART) among people living with human immunodeficiency
virus (PLHIV) is a critical challenge in many African countries including Burkina Faso. Delivering text messaging (short message
service, SMS) interventions through mobile phones may help facilitate health service delivery and improve patient health. Despite
this potential, no evaluations have been delivered for national scale settings to demonstrate the impact of mobile health (mHealth)
for PLHIV.
Objectives: This study aims to test the impact of SMS text messaging reminders for PLHIV in Burkina Faso, who are under
ART. The evaluation identifies whether patients who receive SMS text messages are more likely to (1) retain in care (measured
as a dichotomous variable), (2) adhere to antiretroviral regimens (measured as the number of doses missed in the past 7 days),
and (3) experience slower disease progression (measured with T-lymphocytes cells). The second objective is to assess its effects
on the frequency of health center visits, physical and psychosocial health, nutrition and whether the type of message (text vs
image) and frequency (weekly vs semiweekly) have differential impacts including the possibility of message fatigue over time.
Methods: This 24-month, wide-scale intervention implements a randomized controlled trial (RCT) to evaluate the impact of
four variants of a mHealth intervention versus a control group. Our sample comprises adult patients (>15 years of age) undergoing
antiretroviral therapy with access to mobile phone services. Multivariate regression analysis will be used to analyze the effect of
the intervention on the study population. Data collection is done at baseline and three follow-up waves 6, 12, and 24 months after
the intervention starts.
Results: The targeted 3800 patients were recruited between February 2015 and May 2015. But political uncertainty delayed the
launch of the intervention until October 2015. Data analysis has not yet started. The first follow-up data collection started in April
2016. To the best of our knowledge, this is the first research that explores the effects of mobile message reminders using a
wide-spread sample across an entire nation over a 2-year horizon, especially in a Francophone African country.
Conclusions: We hypothesize that the interventions have a positive impact on retention in care and adherence to ART schemes
and that a more sluggish disease progression will be observed in the short run. However, these benefits may fade out in the long
run. The study expects to advance the research on how long mHealth interventions remain effective and when fatigue sets in the
context of wide-scale interventions. This information will be useful in designing future wide-scale mHealth interventions in
developing countries.
(JMIR Res Protoc 2016;5(3):e170)   doi:10.2196/resprot.5823
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Introduction
Background
Several factors inhibit retention in care and adherence to
antiretroviral therapy (ART) among people living with human
immunodeficiency virus (PLHIV). Typical reasons include
individual and social obstacles, such as lack of information on
treatment procedures, social stigma, discrimination, and
competing priorities that prevent patients from considering
antiretroviral treatment as a worthwhile investment of time,
energy, or resources [1,2]. In developing countries, economic
and contextual barriers may further amplify these challenges
because patients are resource-constrained and health facilities
may not be easily accessible leading to substantial costs in terms
of wage losses and travel expenses [3].
Discontinuation of ART regimens is particularly prevalent in
Sub-Saharan Africa. Systematic reviews have found that
approximately 22.5% of patients discontinue ART within 10
months and 56% are lost to follow-up or death during the first
2 years of the treatment [4,5]. HIV patients are perhaps not fully
aware of the long-term consequences of dropping out from ART
treatment. Lack of retention in care and adherence to
antiretroviral therapy increases HIV viral loads and the
probability of transmission, reduces the number of
T-lymphocytes cells in the blood (CD4 count)-an indicator of
how well the immune system is working and a strong predictor
of HIV progression-leads to deterioration in the quality of life
and can be responsible for creating virus strains that are resistant
to current HIV medication [6-9]. Favorable health outcomes
for PLHIV require lifelong compliance with ART programs.
At the macro-level the negative side effects of poor compliance
with ART can deteriorate the efficiency and efficacy of public
health care systems by increasing the burden of the disease and
the potential costs of care in the future [10-12].
The World Health Organization (WHO) promotes the use of
innovative mobile technologies to overcome barriers that
undermine access to health care and the quality of care delivery
in resource-poor countries [13]. mHealth is an important element
of this approach as it can help alleviate some of the existing
obstacles in the delivery of quality care [14-16]. Mobile
technologies may help patients undergoing ART to maintain
the treatment routine as they provide instant communication
unrestricted to location [17,18]. Specifically, the use of text
messaging (short message service, SMS) reminders may support
PLHIV to take their pills every day, schedule refills of their
prescriptions, and assist them through common side-effects.
Such reminders are considered to be a low-cost, low-barrier
intervention [19]. Especially in resource-constrained developing
countries where some patients live far from the health centers
and a system of regular home visits by health care providers is
not in place [1-3], regular text messages may help patients to
remain in care and adhere to their antiretroviral regimens
[20-22]. These advantages have promoted the rapid expansion
of mHealth projects that aim to improve health outcomes in
patients living with HIV and other diseases across the
developing world [23].
Despite the possibility of cost-efficient, easy outreach through
SMS, recent studies have shown contrasting evidence. While
several studies have demonstrated that mobile text message
reminders are effective in enhancing adherence to ART
programs [24-28] others do not find any effects [29,30].
Research in Kenya demonstrates that 53% of the participants
who received weekly SMS reminders achieved adherence of at
least 90% during the 12 months of the study [24]. In the control
group, only 40% of the participants achieved similar adherence
levels. Evidence from a small study in Brazil also suggests that
adherence to ART increased due to text message reminders at
least during the 4-month study period [28]. In contrast, a
6-month study in Yaoundé, Cameroon, found that standardized
motivational mobile text messages did not increase adherence
[29]. Likewise, research conducted in some states in India did
not find a statistically significant impact of mobile phone
reminders on time to virological failure or ART adherence at
the end of a 2-year study period [30]. Moreover, we are not
aware of any long-term study that has been conducted in a
Francophone African country where perceptions, preferences,
and health systems are considerably different as compared with
Anglophone African countries [31].
Justification
The background provided above motivates continued research
on the impact of mHealth interventions in developing countries.
The majority of the existing studies are limited to geographically
circumscribed areas such as capital centers, and are based on
small sample sizes or on short-time horizons [24-30]. For
instance, the Brazilian study carried out a 4-month study with
as few as 21 Brazilian female PLHIV [28]. Similarly, the 2
studies in Kenya followed less than 550 participants and
included no more than 3 health facilities for a period of 12
months [24,27]. The intervention in Cameroon included 1
hospital and 198 participants for a period of 6 months [29].
While the intervention in India had the longest time horizon of
2 years and a relatively large sample of 631 participants it was
based on data from 3 health centers located in only 2 states [30].
Thus, research based on a sample across an entire nation with
a longer-term horizon is warranted. The present study is timely
as it is based on a wide-spread intervention across Burkina Faso
with a 2-year horizon. These design features improve the study’s
external validity. Furthermore, the study will enhance our
understanding of the extent to which mHealth interventions
promote healthy behaviors and support psychosocial wellbeing.
Therefore, the study will contribute to an improved
understanding of when, why, and for whom mHealth
interventions work [32,33].
Objectives
The main objective of this trial is to determine the impact of
four different packages of SMS message reminders to promote
HIV patients’ retention and adherence to ART as well as their
health outcomes in a large-scale randomized controlled trial
JMIR Res Protoc 2016 | vol. 5 | iss. 3 | e170 | p.2http://www.researchprotocols.org/2016/3/e170/
(page number not for citation purposes)
Wagner et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
(RCT) in a Francophone country, namely Burkina Faso. We
hypothesize that patients who receive text messages are
encouraged to take their pills and reminded of the importance
of ART for their health so that they remain in care longer than
those who do not receive text messages. We also anticipate that
enhanced retention and adherence will lead to positive health
outcomes. Our objectives are (1) to inform best practices for
enrolling PLHIV into ART programs and supporting them
throughout care, (2) to provide insights on the key obstacles
confronting patient retention and adherence to ART, (3) to
advise on the most effective application of mobile technology
for health interventions, including the short-, medium-, and
long-term benefits that can be anticipated, and (4) to encourage
long-term patient success with ART by promoting feasible and
efficient strategies that may be adopted in resource-constrained
settings. Concerning the effectiveness of SMS text messaging
reminders, our intervention includes two complementary
objectives. First, the study evaluates whether patients may
experience fatigue from the SMS text messaging reminders. By
carrying out 3 surveys at 6, 12, and 24 months after the launch
of the intervention, we aim at determining the optimal period
for such a type of mHealth intervention to be efficient. Second,
the trial will evaluate the effects of message type (text vs ASCII
image) and frequency (weekly versus semi- weekly), i.e., the
differences in the four treatment arms, on patient outcomes.
Methods
Trial Setting
The study is implemented in the Francophone African country
of Burkina Faso. The Joint United Nations Programme on
HIV/AIDS (UNAIDS) reports that this country suffered a HIV
prevalence of 0.9 in 2014 and the total number of PLHIV is
estimated to be around 110,000 of which 94,000 are adults and
18,000 are children younger than 15 years [34]. The feminization
of HIV is also observed in Burkina Faso since 59 percent of the
adult PLHIV are women according to the National Council for
the Fight against AIDS and Sexually Transmitted Infections
(CNLS-IST) -the national committee in charge of the
surveillance and fight against HIV/AIDS. The country provides
free anti-retroviral treatment and its provision of HIV care
follows WHO’s international guidelines and strategies [35,36].
Burkina Faso’s National Plan to combat HIV includes
decentralization policies and multisector participation with the
aim to increase the number of PLHIV who enroll at health
centers that provide ART therapy and care [37]. Despite these
efforts the fight against HIV and for ART adherence and
retention remain a concern. Although the actual number of
PLHIV enrolled in official files increased from 70,230 in 2013
to 76,342 in 2014, the actual number of patients undergoing
active antiretroviral treatment was only 60% (42,145) in 2013
and 61% (46,623) in 2014. Similarly, despite the fact that the
number of patients that becomes lost to follow up decreased
almost by half from 2013 to 2014 (833 to 443), they are all
attributed to fatalities [34]. These figures provide a first
indication that adherence and retention to ART cannot be
assured in Burkina Faso. And indeed, a survey carried out by
UNAIDS in 2012 among 2,800 Burkinabe PLHIV revealed that
adherence is perceived as a challenge due to negative side effects
from treatment, the time and resources needed to regularly refill
the stock of drugs and stigma [38]. The study we aim to
implement allows us to assess whether and how retention and
adherence may be improved.
Study Design
The study design rests on a five-arm, randomized, controlled
trial with four treatment arms and one control group. With the
support of the Burkinabe Ministry of Health and local health
centers, HIV patients have been screened and recruited at 80
health care facilities that provide antiretroviral therapy across
the 13 regions of Burkina Faso. Using a 7:7:7:7:10 allocation
ratio, patients are randomized to one of the five-arms with the
control group being slightly oversampled as we introduce two
types of control groups; a control group of patients drawn from
health centers which do not receive any of the interventions and
a spillover-prone control group drawn from health centers which
are visited by both treated and untreated patients. A member of
the international survey team carried out the randomization in
Stata. The team member did not have any interactions with
patients. Once patients were randomly allocated, the intervention
was launched and the SMS messages are sent. Patients in each
of the five groups receive the public standard care but only four
groups receive an SMS reminder that varies by the type of
message (text versus American standard code for information
interchange (ASCII) image) and its frequency (weekly vs
semiweekly). The study collaborates with the health care
personnel attending to the patients as well as the associations
and self-help groups that provide psychosocial support to
PLHIV. The former provide medical information and the latter
carry out the survey interviews. The health personnel and the
enumerators are not informed about the outcome of the random
allocation of the participants. Because they do not know which
patient is in which group, we do not expect bias. The study will
keep track of the patients 6, 12, and 24 months after the
intervention is launched.
Facilities Selection
The investigation will be implemented in health facilities across
the 13 regions of Burkina Faso. The health centers are selected
from a total of 100 registered facilities that are recorded in the
documents of the CNLS-IST as providers of antiretroviral
therapy across the 13 health care regions of Burkina Faso [34].
To be eligible to participate in this study, health centers need
to fulfill two conditions. First, they need to exist and they need
to be functioning. While this sounds like a straightforward
requirement it is possible that despite being registered, facilities
might have never become operational or have shut down.
Second, the health centers need to be willing to collaborate.
Specifically, we enrolled a total of 80 health centers with an
intended average of 40 patients being recruited per center
depending on the eligible population of PLHIV who frequent
the health center. To avoid under or overrepresentation of a
particular health center, eligible facilities must meet a minimum
number of 15 HIV patients and are allowed to enroll a maximum
number of 150.
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Participants
Eligibility and Informed Consent
The participants need to fulfill five conditions. As an initial step
for eligibility, participants must be enrolled in an ART program
in 1 of the health care centers collaborating in the study. Second,
each patient must provide written informed consent confirming
their participation in the study. The informed consent includes
signed permission to consult their medical records over the
duration of the study. Third, participants must be older than 15
years because the focus of the study is on adult PLHIV. Fourth,
participants who have been under ART for less than 4 years are
preferred, although, experienced patients are also included. We
aim at assessing differential effects for individuals initiating
ART versus individuals who have been under treatment for a
long time. Because the existing literature suggests that drop-out
is highest among those initiating treatment, we place more
emphasis on individuals who have recently started ART.
Therefore, we aim that at least two-thirds of the sample consists
of patients that have been under ART for less than 4 years. We
trained and informed the health centers and enumerators about
this sampling feature. We requested to be informed (by phone)
in the case that patients were included, that have been longer
on ART. Thus, from the central level we closely monitored the
oversampling of patients, who have been under ART for less
than 4 years. Fifth, patients must have reliable access to a mobile
phone including a stable network connection. Access to a mobile
phone is not a major bottleneck: according to the World
Factbook there were 12.5 million subscribers in Burkina Faso
in 2014, 68 of 100 inhabitants have a mobile phone, and there
are 3 major mobile networks that reach out to the entire country
[39,40].
Recruitment
The recruitment period lasted for 4 months because patients
return to the health centers to refill their stock of antiretroviral
medication at different intervals. This time period has been
sufficient to reach the target sample size of 3800 individuals.
Randomization
Randomization was undertaken after the collection of the
baseline data. As a first step we randomly identified 8 pure
control health centers using the random number generator in
Excel. These pure control centers allow us to assess whether
there are within health center spillovers from those who receive
reminders and those who do not. Across the 72 remaining health
centers, we randomly assign individuals to 1 of 5 groups (ie, 1
of 4 treatment packages or the control group of patients who do
not receive any text message). Due to the potentially large
heterogeneity of patient socioeconomic profiles and variations
across health centers, the study applies covariate balancing
across multiple baseline covariates to minimize imbalance
between treatment groups. To increase statistical power and the
precision of the results, participants are ordered along key
characteristics and randomized within these ordered blocks. The
following characteristics are included in the ordering: gender,
age and weight of the participant, duration under antiretroviral
treatment, health center identifiers, the reported distance to the
health center, CD4 counts, and subjective health rating.
Following this 2-step procedure, participants are randomly
assigned to 1 of 5 groups (4 of which receive various packages
of SMS reminders and a control group, which does not). Thus,
there are 2 control groups. One control group consists of
individuals who do not receive messages but are affiliated to
health centers where others receive messages and a pure control
group, which consists of individuals who do not receive
messages and are affiliated to the 8 pure control health centers
where no one receives a message. The introduction of 2 types
of control groups is motivated by a desire to address potential
spillovers/contamination between treated persons (those who
receive a SMS text message) and patients in the control group
(those who don’t receive the SMS text message) but frequent
the same health center. We know that medical interventions
such as deworming and cancer screenings have spillovers
[41,42], similarly voter awareness and cash transfer programs
have spillovers to untreated but close populations [43,44].
Having 2 control groups allows us to address whether both
treated and untreated patients in the treatment health centers are
covered by the intervention [43]. In the analysis, we will
introduce a dichotomous variable for control patients from
mixed-treatment control sites to assess whether their outcomes
differ compared with patients from pure control sites who are
unlikely to experience spillovers.
Intervention
The intervention comprises 4 treatment groups and 1 control
group to investigate the impact of different types of SMS text
message reminders sent out at different frequencies on patient
outcomes. For groups 1 to 4, messages will be sent on a weekly
basis. Patients of each of the 4 treatment groups will receive at
least 1 text or image message per week. Image messages are
used to ensure that the intervention reaches out to people with
limited literacy skills and they will be sent as ASCII pictures.
Because we do not expect the participants to have smartphones,
we use ASCII images that can be displayed on basic mobile
phones. The content and frequency of the messages will vary
for each of the 4 treatment groups. While the first treatment
group will receive only 1 text message per week (low
frequency), the second treatment group receives a total of 2 text
messages per week (high frequency). Meanwhile, the third group
will get 1 text and 1 image message per week and, the fourth
group will receive 2 image messages per week. All messages
will be sent at 8 am and patients will not be prompted to respond.
The impact of the treatments will be assessed in follow-up
surveys at 6, 12, and 24 months after the start of the intervention.
A detailed identification of the 5 groups, type of interventions,
and timings are presented in Table 1.
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Table 1. Identification of the five intervention groups.
TimingIntervention
(per week)
Treatment arms
Control group
No text nor image mes-
sages
Eight pure control health centers
Individuals from the remaining
72 centers randomly allocated to
the control group.
Every Monday at 8 amOne text messageTreatment 1: text-only, low frequency
Every Monday and Friday at 8 amTwo text messagesTreatment 2: text-only, high frequency
Text: every Monday at 8 am;
image: every Friday at 8 am
One text message;
one image message
Treatment 3: text and image
Every Monday at 8 amOne messageTreatment 4: image only
Furthermore, text messages are sent in French or 1 of the local
languages (Moore, Jula, Gulmancema, Fulfulde, or Dagara).
The baseline survey determined the main language of each
participant to be used in the text messages. The content of the
text messages will vary to ensure that the participants remain
curious about the messages over the study period. We are
concerned that individuals stop looking at an identical message
after some time as they already know the content of the
standardized message. Furthermore, we opted for a mix of
messages instead of standardized messages due to concerns
about exclusively “negative” framing (Textbox 1). However,
we acknowledge that this approach does not allow us to
systematically compare the implications of standardized
messages across different treatment arms. Figure 1 shows two
examples of the ASCII images that are sent.
Textbox 1. Examples of the text messages that are sent.
Hello. Do not forget to take your pills.
Your health is important. Take your pills.
You are very important. Do not play with your health. Take your pills.
Are you very busy? This is why I remind you to take your pills.
Don’t forget that you are strong, unique, funny and blessed. You are needed. This is why I would like to remind you to regularly take your pills.
Patients in the control group do not receive any text messages
but only the standard care. Along with periodic clinical
check-ups and treatment counseling, this includes routine
monitoring of patient CD4 cells as measure of disease
progression. Adherence support and/or additional treatment
counseling may also be provided at the community level. This
will be assessed during follow-up surveys.
Figure 1. Examples of ASCII images used in the intervention.
Sample Size
Power calculations need to account for the stratified nature of
the sample. There are 80 treatment centers. We randomly
preserve 8 pure control centers to assess spillovers. Within each
of the remaining 72 centers, treated and untreated participants
are sampled. Thus, for the majority of the centers treatment
allocation is not at the level of the center but at the level of the
individual. The sample size is calculated with the clustersampsi
command of Stata, Version 13 assuming a power of 80% and
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a significance level of 5%. Furthermore, we impose an intraclass
correlation coefficient of 0.015 to quantify the degree to which
patients within the same health center are related [45]. We allow
for cluster sizes to vary because we know that the size of the
eligible population varies across clusters. Thus, we impose a
coefficient of variation of cluster sizes of 0.5 (ratio of the
standard deviation of cluster sizes to the mean cluster size).
Because we collect baseline information we can control for
observable characteristics and their correlation with the outcome.
We impose a correlation of 0.85. Lastly, because we expect that
35% of the patients will forget to take antiretroviral (ARV)
medication from time to time, a target sample size of 3800
PLHIV is needed to obtain a “minimum detectable effect” of
an increase in adherence from 65% to 70%. These adherence
figures are based on a reported 67% adherence among female
PLHIV in Burkina and the government target to bring adherence
up to at least 80% [37,38]. As we are conservative about the
possibilities of mHealth to raise adherence by 15% the sample
was set up in such a way to also identify small gains.
Duration and Follow-Up Surveys
The intervention will run for a period of 2 years. We will
conduct four outcome assessments during baseline as well as
6, 12, and 24 months into the intervention.
Ethical Concerns
The study faces two ethical concerns. First, we need to access
patient medical records to monitor health indicators. We need
to gain participant consent and have to ensure that confidentiality
is protected during the period of the study. Only the health
personnel and the local enumerators will know the individuals.
In the dataset, all patient information will be anonymous and
only linked to the participant's identification number that is
given in the context of the study. No identity information will
be disclosed. Second, as evident in the examples provided above,
in order to prevent negative social stigma, the reminders do not
disclose a participant's seropositive status. Participants will be
informed of the possibility that texts could be read by other
individuals who have access to their phone and they will have
to consent to this risk in order to participate in the study.
All relevant ethical clearance from the national ethics committee
has been obtained (N° 2014-12-144).
Implementation of the Text Message Reminder System
The local telecommunication company EVOLE provides a
computerized platform for sending the SMS text message
reminders, re-launching text messages if delivery fails, and
monitoring message receipt. The messages are sent in bulk and
a record is kept of all communication. The computerized
platform allows us to verify whether the text and image
messages have been sent and that the intervention has been
properly implemented. We will also use the monitoring data to
analyze the quality of the SMS text message communication.
Details about the study design, facility selection, and patient
eligibility including the random allocation mechanism, the
intervention and the outcome variables are graphically presented
in Figure 2.
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Figure 2. Study flow.
Study Measures
Primary Outcomes
The study focuses on the measurement of three primary
outcomes: retention in care, adherence to ART, and disease
progression. Retention is measured by a dichotomous
variable-whether a patient remains on ART 6, 12, and 24 months
after the intervention has started as compared with baseline
[46,47]. Retention could have been conceptualized also as the
incidence or number of missed visits during a given reference
period [48]. However, remaining in care is in itself an important
challenge in Burkina Faso. This is in stark contrast to the
situation of PLHIV in developed countries. Therefore, we
decided to choose remaining on an ART regimen as our retention
measure. Adherence or rather lack of adherence to ART is
evaluated as the number of doses missed in the past 7 days,
which is a self-reported measure [49-51]. It may have been
better to use actual pharmacy dispensing data to calculate a
medication possession ratio. However, our field experience
suggested that it was not always feasible to obtain detailed and
correct information about pharmacy dispensing. Contrary to
developed countries where standards across hospitals may be
similar, in Burkina Faso we observed considerable differences
in the standards and routines across health centers both between
regions and within them. Because we assess a wide-scale
intervention our study also includes rural and remote areas,
which are perhaps even less capable of providing this
information. Therefore, we opted for inclusiveness knowing
that this implies adjustments in the type of comparable indicators
that can be collected and analyzed across health centers [51].
Lastly, disease progression is analyzed using patients’ CD4
counts.
Information on these primary outcomes will be collected using
individual questionnaires and patient medical records. Table 2
presents details about the indicators with information about the
date of data collection.
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Table 2. Primary and secondary outcome variables.
Follow-ups (months af-
ter)
BaselineIndicators/measuresClassification
24126
Primary outcomes
XXXXDichotomous measure whether a patient
remains on ART
Retention in care
XXXXNumber of doses missed in the past 7
days
ART adherence
XXXXCD4 countDisease progression
Secondary outcomes
XXXIncidence and number of missed visitsHealth center visits
XXXXBiomarker: body mass indexPatient health
XXXXIncidence of coinfection
XXXXMortality
XXXXSubjective health rating
XXMeasures of mental health
XXRisk preferencePreferences
XXSubjective discount factor
XXNutrition
XXX Comparison of the four interventionsMessage type and frequency
XXX Patients' perceptions of the interventionMessage fatigue
Secondary Outcomes
Information on 5 groups of secondary outcomes will be
collected. First, we will obtain information about the incidence
and number of missed health center visits. Second, because we
are also interested in more general physical and psychosocial
health aspects we will gather information about the body mass
index, the incidence of coinfections, mortality, as well as
subjective and mental health ratings. In addition, we will collect
information on the patients’ levels of risk preference and their
subjective discount factors. Third, we will also measure
nutritional outcomes. Fourth, to assess design effects and the
duration of effectiveness of the mHealth intervention, we will
gather data on the message type and frequency. The sensitivity
to message type (text vs ASCII image) and the frequency
(weekly vs semiweekly) of receiving the messages will be
measured by comparing the effects of the 4 different
interventions on the primary outcomes [24-30]. Finally, message
fatigue will be measured using patients’ perceptions and possible
changes in the impact on the primary outcome indicators across
follow-up survey rounds. The secondary outcomes will be
measured 6, 12, and 24 months after commencement of the
intervention.
Analysis Plan
Our analysis will exploit the randomized nature of the
intervention to attribute treatment effects. In addition to a simple
comparison between the pooled treatments and the control group
we will also assess the differential impact of the 4 treatment
arms. We will employ multivariate regression models to assess
the impact of the interventions on each of the primary outcome
variables. For the continuous outcome measure (CD4 count)
we plan to employ an Ordinary Least Squares model. For the
count data (pill doses missed) and if the continuous outcome
measure is skewed, we propose to make use of a Poisson model;
for the dichotomous outcome (remaining on ARV regimen),
we propose to employ a Logit model. In all models we will
control for the clustering of participants within health centers.
We will make use of the coefficient estimates from the 4
treatment arms to establish a preference ordering of the
effectiveness of the different types (text vs ASCII image) and
frequencies (weekly vs semiweekly) of the SMS text message
reminders. We will also estimate quantile regressions to identify
which group(s) of participants are most (least) likely to have
gained from the interventions. Comprehensive data on patient
characteristics collected at baseline will allow us to control for
confounding factors and patient heterogeneity. These patient
characteristics include age, gender, ethnicity, education, whether
the patient is the head of the household, income, and whether
the patient works. The simple comparison of outcome variables
across groups will be complemented by a
difference-in-difference identification strategy where we jointly
employ the data from the three follow-up surveys. This analysis
will permit us to tease out the differences in health outcomes
attributable to each of the 4 interventions while controlling for
time-fixed effects.
The data will be collected and coded by trained enumerators
and analyzed using the statistical and data analysis program
STATA. We will use conventional levels of significance at 1%,
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5%, and 10%. Because we identified three primary outcome
variables we will make use of an inflated alpha when
determining significance levels for each and every outcome
separately. We apply this correction because the more
significance tests we conduct at α=0.05, the more likely we are
to claim that we have a statistically significant result. For a
significance level of 5% the Bonferroni inflated alpha is 0.05/3
= 0.015.
We expect missing data to be below 5% and plan to address it
using imputation techniques. However, the technique that we
do use will depend on the characteristics of the missing
information. Our goal is to avoid reducing the sample size
without compromising statistical validity.
Results
Our project finished the recruitment of patients in May 2015.
We have recruited the targeted 3800 patients across the 80 health
centers and even oversampled by 38 patients. We kept 8 pure
control health centers and randomized participants in the
remaining 72 treated health centers across the treatment arms
and the control group. The intervention started in October 2015
and follow-up data collection has started in April 2016. Analysis
of the intervention has not yet started. The project was
challenged by the sociopolitical instability in Burkina Faso
during 2014, 2015, and early 2016. The initial launch of the
study coincided with a coup d’état in Burkina Faso in November
2014. Despite the political turmoil in the country, the study
received ethical clearance from the Burkinabe Ethics Committee
for Research in Health in December 2014. A second coup d’état
in September 2015 further challenged the project. But we could
continue with the project and launch the intervention in October
2015. In January 2016, the terrorist attacks in Burkina Faso’s
capital Ouagadougou added another layer of uncertainty to the
project. Throughout the sociopolitical instabilities in the country
the local and the international team managed to keep the project
running. We therefore expect that we can successfully complete
the project and conduct the intended analysis as outlined in this
protocol.
This intervention is funded by 3ie-International Initiative for
Impact Evaluation and conducted by the International Institute
of Social Studies of Erasmus University of Rotterdam in
collaboration with Univsersité Polytechnique de
Bobo-Dioulasso.
Discussion
Summary
To date, very few rigorous evaluations have examined the impact
of SMS text messaging reminders on retention and adherence
of PLHIV. Existing studies are based on small samples not
delivered widely at a national scale and tend to focus on short
time horizons [24-30]. To the best of our knowledge, this study
will be the first long-term RCT to assess the effects of a mHealth
intervention using an intervention that is delivered at national
scale. The study will also assess the effects of message type
(text vs ASCII image) and frequency (weekly vs semiweekly),
as well as, whether patients experience message fatigue over
the course of the 2-year period of the intervention. To assess
the impact of this intervention in a multivariate fashion, we will
collect information on sociodemographic traits and several
diseases-related outcome indicators. The findings of this study
will enhance understanding of how interventions using mobile
technology can influence HIV care and treatment. The
conclusions from this study will contribute to more informed
recommendations for mHealth in health care provision and the
development of national and international guidelines for
mHealth usage. We expect to define when, why, and for whom
mHealth interventions may work. The findings may also be
applicable to other African countries, which have similar
epidemiological HIV profiles and social conditions as in Burkina
Faso.
Limitations
We are not able to control for all possible external factors that
may influence the results. These factors include, among others,
appropriate supply of medication, political or civil struggles
that may influence the functioning of the health system, and
other community-level changes during the 2-year intervention
period. All these contextual confounders will be documented
and considered while interpreting the findings.
Conclusions
This study aims to contribute to the evidence on mHeath usage
to support HIV care delivery in resource-poor settings. We will
evaluate the impact of mHealth interventions for care and
treatment of PLHIV, and thereby expect to inform strategies to
improve health-related outcomes among specific populations.
The study expects to advance the research on how long mHealth
interventions remain effective in the context of wide-scale
interventions in developing countries. We will determine the
impact of mHealth in the short-, medium-, and long-term, and
thus advance understanding of how mHealth interventions may
complement other social and behavioral health interventions in
developing countries.
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